Literature DB >> 12296859

Long-term antibody responses following human infection with Campylobacter jejuni.

S A Cawthraw1, R A Feldman, A R Sayers, D G Newell.   

Abstract

Epidemiological evidence suggests prior infection of humans by Campylobacter jejuni leads to protection against disease following further exposure. It is known that infections elicit strong antibody responses following the onset of disease and that antibody levels are elevated in putatively immune populations. To determine if systemic and mucosal antibodies induced by a confirmed infection remain at elevated levels for prolonged periods, repeat serum, saliva and urine samples were taken from campylobacter patients from 1 week and up to a year postinfection. Antibodies were monitored by ELISAs using three different antigen preparations: acid-glycine extracts (AE) of C. jejuni strain 81116 and an aflagellate mutant (R2), and a whole-cell R2 sonicate, and by Western blotting. Levels of serum IgG antibodies against 81116AE and R2 sonicate, but not R2AE, remained significantly raised over time when compared to a comparison population. Serum anti-sonicate IgA antibody levels were initially significantly raised but decreased over time to levels similar to the comparison group. There were no significant differences in levels of salivary IgA against the AEs. Anti-sonicate salivary IgA and IgG levels were initially significantly higher than in the comparison group. Both declined over time but the IgG levels remained significantly higher. Significant correlations were seen between serum IgG levels and age and duration of illness. Serum antibodies against flagellin, 40 kDa and 29 kDa antigens were still detectable in most patients up to a year postinfection, as were salivary antibodies to flagellin, the major outer-membrane protein and a 40 kDa antigen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12296859      PMCID: PMC1906500          DOI: 10.1046/j.1365-2249.2002.01966.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Monoclonal antibodies directed against the flagella of Campylobacter jejuni: production, characterization and lack of effect on the colonization of infant mice.

Authors:  D G Newell
Journal:  J Hyg (Lond)       Date:  1986-04

2.  Demonstration of a flagellar antigen shared by a diverse group of spiral-shaped bacteria that colonize intestinal mucus.

Authors:  A Lee; S M Logan; T J Trust
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

3.  The identification of outer membrane proteins and flagella of Campylobacter jejuni.

Authors:  D G Newell; H McBride; A D Pearson
Journal:  J Gen Microbiol       Date:  1984-05

4.  A study of infectious intestinal disease in England: microbiological findings in cases and controls.

Authors:  D S Tompkins; M J Hudson; H R Smith; R P Eglin; J G Wheeler; M M Brett; R J Owen; J S Brazier; P Cumberland; V King; P E Cook
Journal:  Commun Dis Public Health       Date:  1999-06

5.  Antibodies, directed towards Campylobacter jejuni antigens, in sera from poultry abattoir workers.

Authors:  S A Cawthraw; L Lind; B Kaijser; D G Newell
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

6.  Campylobacter jejuni-specific serum antibodies are elevated in healthy Bangladeshi children.

Authors:  M J Blaser; R E Black; D J Duncan; J Amer
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

7.  Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay.

Authors:  M J Blaser; D J Duncan
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

8.  Monoclonal antibodies directed against the flagella of Campylobacter jejuni: cross-reacting and serotypic specificity and potential use in diagnosis.

Authors:  D G Newell
Journal:  J Hyg (Lond)       Date:  1986-06

9.  Campylobacter jejuni outer membrane proteins are antigenic for humans.

Authors:  M J Blaser; J A Hopkins; M L Vasil
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

10.  Superficial antigens of Campylobacter (Vibrio) fetus: characterization of antiphagocytic component.

Authors:  E C McCoy; D Doyle; K Burda; L B Corbeil; A J Winter
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

View more
  13 in total

Review 1.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

2.  Modification of the Campylobacter jejuni N-linked glycan by EptC protein-mediated addition of phosphoethanolamine.

Authors:  Nichollas E Scott; Harald Nothaft; Alistair V G Edwards; Maurizio Labbate; Steven P Djordjevic; Martin R Larsen; Christine M Szymanski; Stuart J Cordwell
Journal:  J Biol Chem       Date:  2012-07-02       Impact factor: 5.157

Review 3.  Host-pathogen interactions in Campylobacter infections: the host perspective.

Authors:  Riny Janssen; Karen A Krogfelt; Shaun A Cawthraw; Wilfrid van Pelt; Jaap A Wagenaar; Robert J Owen
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

4.  Identification of Campylobacter jejuni genes involved in the response to acidic pH and stomach transit.

Authors:  Anne N Reid; Reenu Pandey; Kiran Palyada; Hemant Naikare; Alain Stintzi
Journal:  Appl Environ Microbiol       Date:  2008-01-11       Impact factor: 4.792

5.  Cytolethal distending toxin (CDT)-negative Campylobacter jejuni strains and anti-CDT neutralizing antibodies are induced during human infection but not during colonization in chickens.

Authors:  Manal Abuoun; Georgina Manning; Shaun A Cawthraw; Anne Ridley; If H Ahmed; Trudy M Wassenaar; Diane G Newell
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 6.  The Host Cellular Immune Response to Infection by Campylobacter Spp. and Its Role in Disease.

Authors:  Sean M Callahan; Carolina G Dolislager; Jeremiah G Johnson
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

7.  Deep Panning: steps towards probing the IgOme.

Authors:  Arie Ryvkin; Haim Ashkenazy; Larisa Smelyanski; Gilad Kaplan; Osnat Penn; Yael Weiss-Ottolenghi; Eyal Privman; Peter B Ngam; James E Woodward; Gregory D May; Callum Bell; Tal Pupko; Jonathan M Gershoni
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

8.  Does age acquired immunity confer selective protection to common serotypes of Campylobacter jejuni?

Authors:  Gordon Miller; Geoff M Dunn; Thomas M S Reid; Iain D Ogden; Norval J C Strachan
Journal:  BMC Infect Dis       Date:  2005-08-23       Impact factor: 3.090

9.  Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database.

Authors:  Clarence C Tam; Sarah J O'Brien; Irene Petersen; Amir Islam; Andrew Hayward; Laura C Rodrigues
Journal:  PLoS One       Date:  2007-04-04       Impact factor: 3.240

10.  Occupational Exposure to Swine, Poultry, and Cattle and Antibody Biomarkers of Campylobacter jejuni Exposure and Autoimmune Peripheral Neuropathy.

Authors:  Leora Vegosen; Patrick N Breysse; Jacqueline Agnew; Gregory C Gray; Irving Nachamkin; Kazim Sheikh; Freya Kamel; Ellen Silbergeld
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.